Overview
Short Course: January 24, 2024 | Virtual
Short Course: February 4, 2024 | In-Person
Short Course: February 4, 2024 | In-Person
Conference: February 5-7, 2024 | In-Person
DIA's Global Pharmacovigilance and Risk Management Strategies Conference is a neutral event developed by regulators and industry experts discussing the updates, opportunities, and challenges alongside fresh problem-solving strategies that matter most to safety professionals.
Participant Testimonials
Informative, collaborative, professional, organized. – Participant
The topics are very relevant to the hot discussions going on right now in the industry, and there is a lot of cross industry experience to learn and discuss these topics. – Participant
It covers wide range of safety related topics, for all levels. And it encourages new learnings. It will give everyone an excellent opportunity to brash up skills. – Participant
Featured
Want to learn more about Global Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!
Today’s Baltimore is a place where good ideas and ambition are the currency that matter most. It’s a place where art is seen as a catalyst for conversation, food as a means of connection, and history as an opportunity for education. It’s an essential destination full of inclusive neighborhoods where all visitors will feel invited, welcomed, and seen. Click here to check out all the tour guides based on your interests.
Discover Baltimore!
Short Course or Primer
To keep you at the forefront.
Program Committee
-
James Buchanan, PharmD President
Covilance LLC, United States -
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States -
Barbara Hendrickson, DrMed, MD Clinical Associate, Pediatric Infectious Diseases
University of Chicago, United States -
Scott Janiczak, PharmD, MPH Research Officer, Division of Pharmacovigilance, OSE, CDER
FDA, United States -
Mamiko Konishi Executive Director, Global PV Management Dept., Global Safety HQs
Eisai Co., Ltd., Japan -
Susan Kindig, JD, MD Executive Director, Medical & Drug Safety
Halozyme, United States -
Mengchun Li, MD, MPA Senior Director, Clinical Research, Infectious Disease
Merck & Co., Inc., United States -
Joseph Paradis, PharmD Associate Director for Medication Error and Risk Management Initiatives, CDER
FDA, United States -
Mark Perrott, PhD Managing Partner
Axian Consulting Limited, United Kingdom -
Sarah Vaughan Head of Vigilance Operations
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Yijing (Hellen) Zhang Executive Director, Global Patient Safety
Beigene, China -
Jeremy Jokinen, PhD, MS Vice President and Head, Global Risk Management and International Patient Safety
Bristol-Myers Squibb Company, United States -
Annette S. Williams, MBA, RPh Vice President, Pharmacovigilance
IQVIA, United States
Have an account?